---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-016137"
form_type: "8-K"
ticker: "OSUR"
cik: "0001116463"
company_name: "ORASURE TECHNOLOGIES INC"
filed_at: "2022-08-09T23:59:59+00:00"
generated_at: "2026-06-24T01:47:02.280386+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OraSure Q2 revenue record $80.2M (+39% YoY) but GAAP EPS ($0.26); InteliSwab sales surge 95% QoQ

## Summary
- GAAP net loss of $18.8M vs. $1.4M loss in Q2 2021; gross margin fell to 34.4% from 53.2%.
- Non-GAAP gross margin improved 250 bps sequentially to 40.1%; non-GAAP EPS ($0.00).
- Q3 revenue guidance $90-95M (67-76% YoY growth); expects positive cash flow by Q4 2022.
- Appointed Ken McGrath as CFO effective Aug 8; three directors resign Nov 8; Mara Aspinall to become Board Chair.
- InteliSwab capacity now ~1.6M tests/week, expected to nearly double by early 2023.

## SEC filing metadata
- accession: 0000950170-22-016137
- form_type: 8-K
- ticker: OSUR
- cik: 0001116463
- company_name: ORASURE TECHNOLOGIES INC
- filed_at: 2022-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1116463/000095017022016137/0000950170-22-016137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1116463/000095017022016137/osur-20220809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-016137
- JSON: https://secwatch.observer/filing/0000950170-22-016137.json
- Plain text: https://secwatch.observer/filing/0000950170-22-016137.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.